Paeds Vivas · infectious-diseases
Common viral exanthems — roseola and erythema infectiosum — branching viva
Branching structured-oral viva on the common benign viral exanthems of childhood: the fever-then-rash timing that anchors roseola (HHV-6 and HHV-7) and the slapped-cheek-then-lace pattern of erythema infectiosum (parvovirus B19), the immune-mediated pathophysiology behind the timing, the host-dependent parvovirus B19 disease spectrum (fetal hydrops, transient aplastic crisis, pure red cell aplasia), the rash differential that excludes meningococcal disease and Kawasaki disease, the selective use of serology and PCR, and the public-health layer of exclusion and pregnant-contact counselling.
On this page & tools
Target exams
Opening question
Examiner: Take me through this child. What is the most likely diagnosis, and what is your frame for managing it? [6]
Candidate: The most likely diagnosis is roseola infantum, also called exanthem subitum or sixth disease. The diagnostic clue is the timing: three days of high fever in a well-looking infant, with the rash appearing only as the fever defervesces. That fever-then-rash sequence is the single best bedside discriminator, because it is the opposite of the rash-with-fever illnesses like measles. My frame is two-layered. First, confirm the benign pattern and exclude the dangerous mimics — a non-blanching rash, Kawasaki disease, a toxic child. Second, identify the host-dependent risks that turn a trivial exanthem into an emergency, because the same virus behaves very differently in the pregnant, haemolytic or immunocompromised contact. For this well infant the management is reassurance and a safety-net. [6] [7]
Examiner: Why are you confident enough to do no tests? [7]
Candidate: Because the story is the diagnosis. Roseola is caused by human herpesvirus 6, occasionally HHV-7, and the population-based Seattle study showed HHV-6 is acquired by almost every child by age two and is the commonest single cause of febrile illness bringing infants to medical attention. The high fever with a well child and no focus, followed by a blanching trunk rash at defervescence, is a pattern diagnosis. Ordering panels of tests on an obvious benign exanthem reflects discomfort with clinical reasoning, not thoroughness — provided I have genuinely excluded the dangerous mimics first. [7] [8]
Branch 1 — pathophysiology and the timing
Examiner: Explain the pathophysiology. Why does roseola cause days of high fever and then a rash, when measles causes the rash while the fever is at its peak? [5]
Candidate: The answer is in the biology of HHV-6 and it explains the timing that makes the diagnosis. The virus enters through the respiratory tract and spreads to regional lymph nodes, where it replicates in T-lymphocytes and monocytes. A high viraemia follows, and the viraemia drives the sustained fever — the child is hot because the virus is circulating in large amounts. The rash does not appear during the viraemia because it is not caused by virus damaging skin cells directly. It appears days later, as the immune response clears the virus, which is why it coincides with the fall in fever. The rash is an immune-mediated exanthem announcing recovery, not a sign of worsening — and that single insight reframes the frightened phone call from a parent whose child develops a rash as the fever breaks: the child is recovering, not deteriorating. [5] [6]
Examiner: And why does the child look so well despite the height of the fever? [6]
Candidate: Because the fever reflects viraemia, not tissue destruction. The host is coping with a circulating virus, and there is no organ damage driving the temperature, which is why the infant remains alert and playful between spikes — the so-called happy well-looking febrile infant. The mismatch between the height of the temperature and the appearance of the child is itself a clinical feature of roseola, and it is the contrast with a toxic, irritable child that points away from the diagnosis. [6] [8]
Branch 2 — the fifth-disease twin
Examiner: The examiner now tells you the child's 6-year-old sibling was sent home from school last week with slapped cheeks and a lacelike rash, and the mother is twenty weeks pregnant. Walk me through that sibling's illness. [1]
Candidate: That sibling has erythema infectiosum, fifth disease, caused by parvovirus B19. Its signature is a two-phase rash: intensely red slapped cheeks that spare the nasal bridge and the skin around the mouth, giving a pale circumoral ring, followed one to four days later by a pink maculopapular rash on the trunk, arms, buttocks and extensor thighs that takes on a characteristic lacelike or reticulate pattern. The lacelike rash fluctuates with heat, sunlight, exercise and bathing and can flicker on and off for weeks as a post-infectious immune phenomenon — so recurrences are expected, not a sign of new infection or treatment failure. The child is well throughout. [1] [2]
Examiner: There is a cruel feature of fifth disease that catches families and clinicians out. What is it? [1]
Candidate: The infectivity. Fifth disease is most contagious in the days before the rash appears, during the non-specific prodromal phase. By the time the slapped cheek is visible and the family seeks help, the child is no longer contagious. So the child showing the rash has already silently exposed their contacts a week earlier — which is exactly why the tracing question matters most for the pregnant mother, not for the child who is already past the infectious window. A child with the visible rash does not need to be excluded on grounds of infectivity, though local guidance may exclude while the child is systemically unwell. [1] [2]
Branch 3 — the host decides: parvovirus B19 in dangerous hosts
Examiner: Parvovirus B19 is tropic for a specific cell. Which, and why does that matter? [1]
Candidate: The virus uses the P blood group antigen, globoside, as its receptor, and globoside is abundant on erythroid progenitor cells in the bone marrow. Once inside, the virus halts red-cell production by killing the precursors. In a child with normal haemopoiesis and a red-cell lifespan of around one hundred and twenty days, this brief arrest is invisible — a few reticulocytes fail to be made and the body's reserve covers it. The host is what turns this trivial arrest into a life-threatening disease, because the consequence depends entirely on how much the host depends on continuous red-cell production. [1] [2]
Examiner: Take me through the three dangerous hosts. [1]
Candidate: First, the child with chronic haemolytic anaemia — sickle cell disease, thalassaemia, hereditary spherocytosis. There the red-cell lifespan is short, perhaps fifteen to twenty days in sickle cell disease, so the marrow runs at a furious baseline rate just to keep up. When parvovirus halts production even briefly, the haemoglobin falls off a cliff because there is no reserve — that is the transient aplastic crisis, a precipitous symptomatic anaemia with reticulocytes near zero, often the first manifestation of parvovirus in a child whose haemoglobinopathy was previously stable. Second, the fetus of a non-immune mother: the fetal marrow is producing red cells at a tremendous rate to support rapid growth, the fetal red-cell lifespan is short, and the immature heart cannot compensate for a sudden fall in oxygen carriage, so the fetus develops severe anaemia, high-output cardiac failure and hydrops, and may die. Third, the immunocompromised host — HIV, transplant, chemotherapy, primary immunodeficiency — who cannot mount the antibody response that would clear the virus, so the result is persistent infection of the marrow and chronic pure red cell aplasia that does not resolve without treatment. The same virus that causes a trivial cheek rash in one child causes fetal death or aplastic crisis in another. [1] [3]
Examiner: How do you treat the immunocompromised host? [4]
Candidate: With intravenous immunoglobulin, which supplies the neutralising antibodies the host cannot make, combined with reduction of immunosuppression where feasible. The diagnosis rests on PCR showing persistent viraemia rather than serology, because the host never makes the antibody that serology depends on. Frickhofen and colleagues established persistent parvovirus B19 as a treatable cause of chronic anaemia in AIDS, and the principle generalises to other immunodeficiencies. This is one of the great treatable causes of chronic anaemia in immunodeficiency, and missing it condemns the child to ongoing transfusion dependence. [4]
Branch 4 — the pregnant contact pathway
Examiner: The mother is twenty weeks pregnant and was exposed to the sibling last week. What do you do? [3]
Candidate: I do not reassure her without testing. The pathway begins with serology to determine her immune status. IgG positive with IgM negative means past infection and immunity — she is protected and the fetus is safe, so I reassure her. IgG negative means she is susceptible and at risk of primary infection, and a rising IgM or seroconversion confirms recent infection. The single distinction, made on a blood test, determines whether she gets reassurance or a fetal-medicine referral. [3] [1]
Examiner: She is non-immune and seroconverts. What now? [3]
Candidate: I refer her urgently to fetal medicine for serial fetal ultrasound for ten to twelve weeks after the infection, because that is the window over which fetal anaemia can develop. Ultrasound looks for the earliest signs of hydrops — ascites, pleural or pericardial effusions, skin oedema, polyhydramnios — and a raised middle cerebral artery peak systolic velocity as a marker of fetal anaemia. If hydrops develops, the intervention is intrauterine transfusion to correct the fetal anaemia, which can rescue a fetus that would otherwise die. The stakes are a live fetus that can be saved by a transfusion versus a stillbirth no one saw coming, and the difference is whether the exposure was recognised and the mother was referred. Enders and colleagues defined the fetal risk that this pathway is built to detect. [3]
Branch 5 — excluding the dangerous mimics
Examiner: Before you send the well infant home, what are you excluding? [1]
Candidate: Three dangerous mimics, each treatable if caught and lethal if missed. First, meningococcal disease: a febrile child with a non-blanching purpuric or petechial rash has meningococcal disease until proven otherwise, regardless of what viral exanthem is circulating in the school — the glass test is the test that separates the lethal diagnosis from the benign one. Second, Kawasaki disease: a child with five or more days of fever plus non-purulent conjunctivitis, red cracked lips, a strawberry tongue, a polymorphous rash or extremity changes needs Kawasaki assessment, because the price of mistaking it for a benign viral exanthem is a coronary artery aneurysm — it is treated within ten days of fever onset to prevent that. Third, sepsis: a toxic, drowsy or rapidly deteriorating child, or one with meningism, demands a sepsis and meningitis workup before I accept a benign viral diagnosis. The point of this topic is not to make clinicians cavalier about febrile rashes; it is to make them confident about the benign ones once the dangerous ones have been excluded. [1] [6]
Wrap
Examiner: Summarise the common viral exanthems stance in one sentence. [1]
Candidate: Recognise roseola on the fever-then-rash timing in a well infant and erythema infectiosum on the slapped-cheek-then-lace pattern in a school-age child, diagnose both clinically in the well host, exclude the dangerous mimics — meningococcal purpura, Kawasaki disease, sepsis — at every encounter, and run the host-dependent pathways the moment the contact is pregnant, haemolytic or immunocompromised, because the same virus that causes a trivial rash in one child causes fetal hydrops, aplastic crisis or pure red cell aplasia in another. [1] [6]
References
- [1]Young NS; Brown KE Parvovirus B19. N Engl J Med, 2004.PMID 14762186
- [2]Heegaard ED; Brown KE Human parvovirus B19. Clin Microbiol Rev, 2002.PMID 12097253
- [3]Enders M; Klingel K; Weidner A; Baisch C; Kandolf R; Schalasta G; Hentschel R; Jilg W; Modrow S Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol, 2010.PMID 20729141
- [4]Frickhofen N; Abkowitz JL; Safford M; Berry JM; Antunez-de-Mayolo J; Astrow A; Cohen R; Halperin I; King L; Mintzer D; et al Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of chronic anemia in AIDS. Ann Intern Med, 1990.PMID 2173460
- [5]Yamanishi K; Okuno T; Shiraki K; Takahashi M; Kondo T; Asano Y; Kurata T Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet, 1988.PMID 2896909
- [6]Hall CB; Long CE; Schnabel KC; Caserta MT; McIntyre KM; Costanzo MA; Knott A; Dewhurst S; Insel RA; Epstein LG Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med, 1994.PMID 8035839
- [7]Zerr DM; Meier AS; Selke SS; Frenkel LM; Huang ML; Wald A; Rhoads MP; Nguy L; Bornemann R; Morrow RA; Corey L A population-based study of primary human herpesvirus 6 infection. N Engl J Med, 2005.PMID 15728809
- [8]Tesini BL Clinical impact of primary infection with roseoloviruses. Curr Opin Virol, 2014.PMID 25462439